Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043484
Filing Date
2021-08-11
Accepted
2021-08-11 16:42:48
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20210630.htm   iXBRL 10-Q 2514607
2 EX-10.1 xene-ex101_12.htm EX-10.1 64093
3 EX-31.1 xene-ex311_9.htm EX-31.1 22873
4 EX-31.2 xene-ex312_7.htm EX-31.2 22914
5 EX-32.1 xene-ex321_8.htm EX-32.1 12327
6 EX-32.2 xene-ex322_6.htm EX-32.2 11913
  Complete submission text file 0001564590-21-043484.txt   6488501

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20210630.xsd EX-101.SCH 45469
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20210630_cal.xml EX-101.CAL 41225
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20210630_def.xml EX-101.DEF 104368
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20210630_lab.xml EX-101.LAB 322819
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20210630_pre.xml EX-101.PRE 226065
12 EXTRACTED XBRL INSTANCE DOCUMENT xene-10q_20210630_htm.xml XML 839883
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 211164105
SIC: 2834 Pharmaceutical Preparations